Background Sepsis is a leading cause of morbidity and mortality in hospitalized patients. Up
to now, there are no well-established longitudinal networks from molecular mechanisms to …

Objective No studies have evaluated the diagnostic value of ischemia-modified albumin
(IMA) for the early detection of sepsis/septic shock in patients presenting to the emergency …

Purpose: The aim of this study was to evaluate thiol/disulfide homeostasis and ischemia-
modified albumin levels with primary open-angle glaucoma, ocular hypertension, and …

Background: Sepsis is a significant contributor of mortality all over the world. Emergency
departments have a critical role for diagnosing a suspected sepsis in a patient, since early …

METHODS: A prospective case control study design was used to determine the sensitivity of
pentraxin 3 in the diagnosis of neonatal sepsis to allow early diagnostic tool. This study was …

The aim of the study was to assess acute kidney injury (AKI) and its contributing risk factors
among neonates to reduce morbidity and mortality. The study included 310 neonates who …

Aim: Neonatal sepsis is the most common cause of morbidity and mortality. Serum ischemia
modified albumin (IMA) is a specific and sensitive marker for ischemic conditions. We aimed …

Background: Necrotizing enterocolitis (NEC) is a disease with high mortality. It is more
present in premature infants and can also happen in term and late preterm neonates. It may …

Abstract Background and Aim: Antenatal corticosteroids are recommended to improve
neonatal outcomes; however, their usage is associated with the development of neonatal …

Objectives Ischemia-modified albumin (IMA) is a new biochemical marker of ischemia. We
aimed to search blood IMA levels in neonates with congenital heart defects. Study Design …